Skip to main content
Disciplines
Automotive Business IT + Informatics Construction + Real Estate Electrical Engineering + Electronics Energy + Sustainability Insurance + Risk Finance + Banking Management + Leadership Marketing + Sales Mechanical Engineering + Materials
Events
DE
EN
Books
Journals
Topic Page
Marketing
Start single access now
Access for companies
EXTENDED SEARCH
Log in
Top
Published in:
Photo-polymerization Read chapter Read first chapter

2019 | OriginalPaper | Chapter

27. Drug Delivery: Localized and Systemic Therapeutic Strategies with Polymer Systems

Authors : Scott Campbell, Niels Smeets

Published in: Functional Polymers

Publisher: Springer International Publishing

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

This chapter expands upon some of the basic concepts regarding drug delivery and takes a tour through various regions of the body that are commonly treated locally with controlled release systems, investigating current research and commercial strategies involving the use of polymeric systems within each region after briefly describing the biology and the typical biological targets of each region. This section includes drug delivery throughout the gastrointestinal tract and to the skin, lungs, brain, and eye, along with several others. The use of polymeric materials for systemic controlled release is then briefly described and thoroughly investigated in a case study on the most common target of systemically delivered nanomedicines: cancer. The chapter concludes with a perspective on where the field of drug delivery is headed in the future.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

inform now
previous chapter Enhanced Oil Recovery
next chapter Organic-Inorganic Hybrid Materials and Their Applications
Literature
1.
N. Huebsch, C.J. Kearney, X. Zhao, J. Kim, C.A. Cezar, Z. Suo, D.J. Mooney, Ultrasound-triggered disruption and self-healing of reversibly cross-linked hydrogels for drug delivery and enhanced chemotherapy. Proc. Natl. Acad. Sci. U. S. A. 111, 9762–9767 (2014)PubMedPubMedCentral
2.
D. Maitland, S.B. Campbell, J. Chen, T. Hoare, Controlling the resolution and duration of pulsatile release from injectable magnetic “plum pudding” nanocomposite hydrogels. RSC Adv. 6, 15770–15781 (2016)
3.
S.V. Sastry, J.R. Nyshadham, J.A. Fix, Recent technological advances in oral drug delivery – a review. Pharm. Sci. Technol. Today 3, 138–145 (2000)PubMedCrossRef
4.
L.M. Ensign, R. Cone, J. Hanes, Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv. Drug Deliv. Rev. 64, 557–570 (2012)PubMedCrossRef
5.
E.M. Pridgen, F. Alexis, O.C. Farokhzad, Polymeric nanoparticle technologies for oral drug delivery challenges of oral delivery. Clin. Gastroenterol. Hepatol. 12, 1605–1610 (2014)PubMedPubMedCentralCrossRef
6.
7.
K. Sonaje, K. Lin, S. Wey, C. Lin, T. Yeh, H. Nguyen, C. Hsu, T. Yen, J. Juang, H. Sung, Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: oral delivery using pH-responsive nanoparticles vs. subcutaneous injection. Biomaterials 31, 6849–6858 (2010)PubMedCrossRef
8.
Q. Xu, L.M. Ensign, N.J. Boylan, A. Schon, X. Gong, J.-C. Yang, N.W. Lamb, S. Cai, T. Yu, E. Freire, J. Hanes, Impact of surface polyethylene glycol (PEG) density on biodegradable nanoparticle transport in mucus ex vivo and distribution in vivo. ACS Nano 9, 9217–9227 (2015)PubMedPubMedCentralCrossRef
9.
K.Y. Win, S. Feng, Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26, 2713–2722 (2005)PubMedCrossRef
10.
E. Cochran, C. Musso, P. Gorden, The use of U-500 in patients with extreme insulin resistance. Diabetes Care 28, 1240–1244 (2005)PubMedCrossRef
11.
M. Chen, K. Sonaje, K. Chen, H. Sung, A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery. Biomaterials 32, 9826–9838 (2011)PubMedCrossRef
12.
L.T. Kuhn, Biomaterials, in Introduction to Biomedical Engineering, 4th edn., ed. by J. Enderle, S. Blanchard, J. Bronzino (Elsevier Academic, Burlington, 2005)
13.
N.A. Peppas, P. Bures, W. Leobandung, H. Ichikawa, Hydrogels in pharmaceutical formulations. Eur. J. Pharm. Biopharm. 50, 27–46 (2000)PubMedCrossRef
14.
15.
16.
N.R. Mathias, M.A. Hussain, Non-invasive systemic drug delivery: developability considerations for alternate routes of administration. J. Pharm. Sci. 99, 1–20 (2010)PubMedCrossRef
17.
J.J. Norman, J.M. Arya, M.A. McClain, P.M. Frew, M.I. Meltzer, M.R. Prausnitz, Microneedle patches: usability and acceptability for self-vaccination against influenza. Vaccine 32, 1856–1862 (2014)PubMedPubMedCentralCrossRef
18.
E.M. Saurer, R.M. Flessner, S.P. Sullivan, M.R. Prausnitz, D.M. Lynn, Layer-by-layer assembly of DNA- and protein-containing films on microneedles for drug delivery to the skin. Biomacromolecules 11, 3136–3143 (2010)PubMedPubMedCentralCrossRef
19.
B.P.C. Demuth, X. Su, R.E. Samuel, P.T. Hammond, D.J. Irvine, Nano-layered microneedles for transcutaneous delivery of polymer nanoparticles and plasmid DNA. Adv. Mater. 22, 4851–4856 (2010)PubMedPubMedCentralCrossRef
20.
M. Kim, B. Jung, J. Park, Hydrogel swelling as a trigger to release biodegradable polymer microneedles in skin. Biomaterials 33, 668–678 (2012)PubMedCrossRef
21.
G. Wiedermann, Patient compliance in the use of Vivotif Berna vaccine, typhoid vaccine, live oral Ty21a. J. Travel Med. 5, 1–2 (1998)PubMedCrossRef
22.
J.S. Boateng, K.H. Matthews, H.N.E. Stevens, G.M. Eccleston, Wound healing dressings and drug delivery systems: a review. J. Pharm. Sci. 97, 2892–2923 (2008)PubMedCrossRef
23.
H. Ueno, T. Mori, T. Fujinaga, Topical formulations and wound healing applications of chitosan. Adv. Drug Deliv. Rev. 52, 105–115 (2001)PubMedCrossRef
24.
Y. Sawadal, M. Ara, T. Yotsuyanagi, K. Sonet, Treatment of dermal depth burn wounds with an antimicrobial agent-releasing silicone gel sheet. Burns 16, 347–352 (1990)CrossRef
25.
A.C. Lee, H. Leem, J. Lee, K. Chan, Reversal of silver sulfadiazine-impaired wound healing by epidermal growth factor. Biomaterials 26, 4670–4676 (2005)PubMedCrossRef
26.
S. Park, J. Koo, H. Suh, Evaluation of antibiotic-loaded collagen-hyaluronic acid matrix as a skin substitute. Biomaterials 25, 3689–3698 (2004)PubMedCrossRef
27.
H. Storrie, D.J. Mooney, Sustained delivery of plasmid DNA from polymeric scaffolds for tissue engineering. Adv. Drug Deliv. Rev. 58, 500–514 (2006)PubMedCrossRef
28.
M.M. Bailey, C.J. Berkland, Nanoparticle formulations in pulmonary drug delivery. Med. Res. Rev. 29, 196–212 (2008)CrossRef
29.
30.
D.A. Edwards, J. Hanes, G. Caponetti, J. Hrkach, A. Ben-Jebria, M. Lou Eskew, J. Mintzes, D. Deaver, N. Lotan, R. Langer, Large porous particles for pulmonary drug delivery. Science 276, 1868–1871 (1997)PubMedCrossRef
31.
E. Rytting, J. Nguyen, X. Wang, T. Kissel, Biodegradable polymeric nanocarriers for pulmonary drug delivery. Expert Opin. Drug Deliv. 5, 629–639 (2008)PubMedCrossRef
32.
M. Beck-Broichsitter, O.M. Merkel, T. Kissel, Controlled pulmonary drug and gene delivery using polymeric nano-carriers. J. Control. Release 161, 214–224 (2012)PubMedCrossRef
33.
F. Ungaro, I. Angelo, A. Miro, M.I. La Rotonda, F. Quaglia, Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises. J. Pharm. Pharmacol. 64, 1217–1235 (2012)PubMedCrossRef
34.
35.
J.S. Patton, C.S. Fishburn, J.G. Weers, The lungs as a portal of entry for systemic drug delivery. Proc. Am. Thorac. Soc. 1, 338–344 (2004)PubMedCrossRef
36.
J.C. Sung, D.J. Padilla, L. Garcia-Contreras, J.L. Verberkmoes, D. Durbin, C.A. Peloquin, K.J. Elbert, A.J. Hickey, D.A. Edwards, Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery. Pharm. Res. 26, 1847–1855 (2009)PubMedCrossRef
37.
M. Dutt, G.K. Khuller, Chemotherapy of Mycobacterium tuberculosis infections in mice with a combination of isoniazid and rifampicin entrapped in poly(dl-lactide-co-glycolide) microparticles. J. Antimicrob. Chemother. 47, 829–835 (2001)PubMedCrossRef
38.
M. Dutt, G.K. Khuller, Sustained release of isoniazid from a single injectable dose of poly(dl-lactide-co-glycolide) microparticles as a therapeutic approach towards tuberculosis. Int. J. Antimicrob. Agents 17, 115–122 (2001)PubMedCrossRef
39.
I.M. El-Sherbiny, S. McGill, H.D.C. Smyth, Swellable microparticles as carriers for sustained pulmonary drug delivery. J. Pharm. Sci. 99, 2343–2356 (2010)PubMedCrossRef
40.
E. Kleemann, M. Neu, N. Jekel, L. Fink, T. Schmehl, T. Gessler, W. Seeger, T. Kissel, Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG–PEI. J. Control. Release 109, 299–316 (2005)PubMedCrossRef
41.
J. Nguyen, T.W.J. Steele, O. Merkel, R. Reul, T. Kissel, Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy. J. Control. Release 132, 243–251 (2008)PubMedCrossRefPubMedCentral
42.
W. Zhang, H. Yang, X. Kong, S. Mohapatra, H.S. Juan-Vergara, G. Hellermann, S. Behera, R. Singam, R.F. Lockey, S.S. Mohapatra, Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat. Med. 11, 56–62 (2005)PubMedCrossRef
43.
X. Kong, W. Zhang, R.F. Lockey, A. Auais, G. Piedimonte, S.S. Mohapatra, Respiratory syncytial virus infection in Fischer 344 rats is attenuated by short interfering RNA against the RSV-NS1 gene. Genet. Vaccines Ther. 5, 1–8 (2007)CrossRef
44.
H. Yamamoto, Y. Kuno, S. Sugimoto, H. Takeuchi, Y. Kawashima, Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. J. Control. Release 102, 373–381 (2005)PubMedCrossRef
45.
K.K. Gill, S. Nazzal, A. Kaddoumi, Paclitaxel loaded PEG5000–DSPE micelles as pulmonary delivery platform: formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation. Eur. J. Pharm. Biopharm. 79, 276–284 (2011)PubMedCrossRef
46.
S. Wohlfart, S. Gelperina, J. Kreuter, Transport of drugs across the blood – brain barrier by nanoparticles. J. Control. Release 161, 264–273 (2012)PubMedCrossRef
47.
P.R. Lockman, R.J. Mumper, M.A. Khan, D.D. Allen, Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev. Ind. Pharm. 28, 1–13 (2002)CrossRefPubMed
48.
49.
H.-L. Liu, M.-Y. Hua, P.-Y. Chen, P.-C. Chu, C.-H. Pan, H.-W. Yang, C.-Y. Huang, J.-J. Wang, T.-C. Yen, K.-C. Wei, Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology 255, 415–425 (2010)PubMedCrossRef
50.
J. Nicolas, S. Mura, D. Brambilla, N. Mackiewicz, P. Couvreur, Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. Chem. Soc. Rev. 42, 1147–1235 (2013)PubMedCrossRef
51.
Z. Pang, L. Feng, R. Hua, J. Chen, H. Gao, S. Pan, X. Jiang, P. Zhang, Lactoferrin-conjugated biodegradable polymersomes holding doxorubicin and tetrandrine for chemotherapy of glioma rats. Mol. Pharm. 7, 1995–2005 (2010)PubMedCrossRef
52.
Z. Pang, H. Gao, Y. Yu, L. Guo, J. Chen, S. Pan, J. Ren, Z. Wen, X. Jiang, Enhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicin. Bioconjug. Chem. 22, 1171–1180 (2011)PubMedCrossRef
53.
H. Gao, J. Qian, S. Cao, Z. Yang, Z. Pang, S. Pan, L. Fan, Z. Xi, X. Jiang, Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles. Biomaterials 33, 5115–5123 (2012)PubMedCrossRef
54.
U. Bickel, T. Yoshikawa, W.M. Pardridge, Delivery of peptides and proteins through the blood–brain barrier. Adv. Drug Deliv. Rev. 46, 247–279 (2001)PubMedCrossRef
55.
L. Illum, Nasal drug delivery – possibilities, problems and solutions. J. Control. Release 87, 187–198 (2003)PubMedCrossRef
56.
J. Piazza, T. Hoare, L. Molinaro, K. Terpstra, J. Bhandari, P.R. Selvaganapathy, B. Gupta, R.K. Mishra, Haloperidol-loaded intranasally administered lectin functionalized poly(ethylene glycol)–block-poly (d,l)-lactic-co-glycolic acid (PEG-PLGA) nanoparticles for the treatment of schizophrenia. Eur. J. Pharm. Biopharm. 87, 30–39 (2014)PubMedCrossRef
57.
F.J. Attenello, D. Mukherjee, G. Datoo, M.J. McGirt, E. Bohan, J.D. Weingart, A. Olivi, A. Quinones-Hinojosa, H. Brem, Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience. Ann. Surg. Oncol. 15, 2887–2893 (2008)PubMedCrossRef
58.
H. Brem, S. Piantadosi, P.C. Burger, M. Walker, R. Selker, N.A. Vick, K. Black, M. Sisti, S. Brem, G. Mohr, P. Muller, R. Morawetz, S.C. Schold, Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 345, 1008–1012 (1995)PubMedCrossRef
59.
S. Kunwar, S. Chang, M. Westphal, M. Vogelbaum, J. Sampson, G. Barnett, M. Shaffrey, Z. Ram, J. Piepmeier, M. Prados, D. Croteau, C. Pedain, P. Leland, S.R. Husain, B.H. Joshi, R.K. Puri, Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro Oncol. 12, 871–881 (2010)PubMedPubMedCentralCrossRef
60.
G.Y. Kim, B.M. Tyler, M.M. Tupper, J.M. Karp, R.S. Langer, H. Brem, M.J. Cima, Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model. J. Control. Release 123, 172–178 (2007)PubMedPubMedCentralCrossRef
61.
U.B. Kompella, A.C. Amrite, R. Pacha, S.A. Durazo, Nanomedicines for back of the eye drug delivery, gene delivery, and imaging. Prog. Retin. Eye Res. 36, 172–198 (2013)PubMedPubMedCentralCrossRef
62.
M.E. Myles, D.M. Neumann, J.M. Hill, Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis. Adv. Drug Deliv. Rev. 57, 2063–2079 (2005)PubMedCrossRef
63.
M.N. Yasin, D. Svirskis, A. Seyfoddin, I.D. Rupenthal, Implants for drug delivery to the posterior segment of the eye: a focus on stimuli-responsive and tunable release systems. J. Control. Release 196, 208–221 (2014)PubMedCrossRef
64.
Y. Chun, B. Chiang, X. Wu, M.R. Prausnitz, Ocular delivery of macromolecules. J. Control. Release 190, 172–181 (2014)CrossRef
65.
66.
N. Kuno, S. Fujii, Recent advances in ocular drug delivery systems. Polymers 3, 193–221 (2011)CrossRef
67.
N. Nagai, H. Kaji, H. Onami, Y. Ishikawa, M. Nishizawa, A polymeric device for controlled transscleral multi-drug delivery to the posterior segment of the eye. Acta Biomater. 10, 680–687 (2014)PubMedCrossRef
68.
M. Allansmith, A. De Ramus, D. Maurice, The dynamics of IgG in the cornea. Invest. Ophthalmol. Vis. Sci. 18, 947–955 (1979)PubMed
69.
H. Sheardown, Critical role for drug delivery in the development of new ophthalmic treatments. Future Med. Chem. 4, 2123–2125 (2012)PubMedCrossRef
70.
S.D. Fitzpatrick, M.A. Jafar Mazumder, F. Lasowski, L.E. Fitzpatrick, H. Sheardown, PNIPAAm-grafted-collagen as an injectable, in situ gelling, bioactive cell delivery scaffold. Biomacromolecules 11, 2261–2267 (2010)PubMedCrossRef
71.
V. Delplace, S. Payne, M. Shoichet, Delivery strategies for treatment of age-related ocular diseases: from a biological understanding to biomaterial solutions. J. Control. Release 219, 652–668 (2015)PubMedCrossRef
72.
T.R. Thrimawithana, S. Young, C.R. Bunt, C. Green, R.G. Alany, Drug delivery to the posterior segment of the eye. Drug Discov. Today 16, 270–277 (2011)PubMedCrossRef
73.
F.M. Veronese, A. Mero, The impact of PEGylation on biological therapies. BioDrugs 22, 315–329 (2008)PubMedCrossRef
74.
J. Jiang, J.S. Moore, H.F. Edelhauser, M.R. Prausnitz, Intrascleral drug delivery to the eye using hollow microneedles. Pharm. Res. 26, 399–403 (2009)CrossRef
75.
S.R. Patel, A.S. Lin, H.F. Edelhauser, M.R. Prausnitz, Suprachoroidal drug delivery to the back of the eye using hollow microneedles. Pharm. Res. 28, 166–176 (2011)PubMedCrossRef
76.
A.L. Gomes dos Santos, A. Bochot, A. Doyle, N. Tsapis, J. Siepmann, F. Siepmann, J. Schmaler, M. Besnard, F. Behar-Cohen, E. Fattal, Sustained release of nanosized complexes of polyethylenimine and anti-TGF-β2 oligonucleotide improves the outcome of glaucoma surgery. J. Control. Release 112, 369–381 (2006)PubMedCrossRef
77.
T. Hoare, S.B. Campbell, W.-I. Wu, J. Yang, P.R. Selvaganapathy, A microinjection device for delivering in situ-gelling hydrogels for posterior segment drug delivery. Invest. Ophthalmol. Vis. Sci. 55, 478 (2014)
78.
M. Patenaude, N.M.B. Smeets, T. Hoare, Designing injectable, covalently cross-linked hydrogels for biomedical applications. Macromol. Rapid Commun. 35(6), 1–20 (2014)PubMedCrossRef
79.
G. Zhu, Y. Zhang, K. Wang, X. Zhao, H. Lian, H. Wang, J. Wu, Y. Hu, H. Guo, G. Zhu, Y. Zhang, K. Wang, X. Zhao, H. Lian, G. Zhu, Y. Zhang, K. Wang, X. Zhao, H. Lian, W. Wang, H. Wang, Visualized intravesical floating hydrogel encapsulating vaporized perfluoropentane for controlled drug release. Drug Deliv. 23, 2820–2826 (2016)PubMedCrossRef
80.
D. Zhang, P. Sun, P. Li, A. Xue, X. Zhang, H. Zhang, X. Jin, A magnetic chitosan hydrogel for sustained and prolonged delivery of Bacillus Calmette-Guérin in the treatment of bladder cancer. Biomaterials 34, 10258–10266 (2013)PubMedCrossRef
81.
Y.L. Traore, Y. Chen, A. Bernier, A. Ho, Impact of hydroxychloroquine-loaded polyurethane intravaginal rings on Lactobacilli. Antimicrob. Agents Chemother. 59, 7680–7686 (2015)PubMedPubMedCentralCrossRef
82.
E.A. Ho, Intravaginal rings as a novel platform for mucosal vaccination. Mol. Pharm. Org. Process Res. 1, 1–2 (2013)
83.
S. Kim, Y. Chen, E.A. Ho, S. Liu, Reversibly pH-responsive polyurethane membranes for on-demand intravaginal drug delivery. Acta Biomater. 47, 100–112 (2017)PubMedCrossRef
84.
S. Yang, Y. Chen, R. Ahmadie, E.A. Ho, Advancements in the field of intravaginal siRNA delivery. J. Control. Release 167, 29–39 (2013)PubMedCrossRef
85.
W.C. Carlyle, J.B. McClain, A.R. Tzafriri, L. Bailey, G. Brett, P.M. Markham, J.R.L. Stanley, E.R. Edelman, Enhanced drug delivery capabilities from stents coated with absorbable polymer and crystalline drug. J. Control. Release 162, 561–567 (2015)CrossRef
86.
L. Lei, S. Guo, W. Chen, H. Rong, F. Lu, Stents as a platform for drug delivery. Expert Opin. Drug Deliv. 8, 813–831 (2011)PubMedCrossRef
87.
T. Keler, V. Ramakrishna, M. Fanger, Mannose receptor-targeted vaccines. Expert Opin. Biol. Ther. 4, 1953–1962 (2004)PubMedCrossRef
88.
T. Sun, Y.S. Zhang, B. Pang, D.C. Hyun, M. Yang, Y. Xia, Engineered nanoparticles for drug delivery in cancer therapy. Angew. Chem. Int. Ed. 53, 12320–12364 (2014)
89.
90.
D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, R. Langer, Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751–760 (2007)PubMedCrossRef
91.
R. Tong, D.S. Kohane, New strategies in cancer nanomedicine. Annu. Rev. Pharmacol. Toxicol. 56, 41–57 (2016)PubMedCrossRef
92.
T.M. Allen, P.R. Cullis, Drug delivery systems: entering the mainstream. Science 303, 1818–1822 (2003)CrossRef
93.
Y.H. Bae, K. Park, Targeted drug delivery to tumors: myths, reality and possibility. J. Control. Release 153, 198–205 (2012)CrossRef
94.
A.A. Gabizon, Stealth liposomes and tumor targeting: one step further in the quest for the magic bullet. Clin. Cancer Res. 7, 223–225 (2001)PubMed
95.
A.K. Iyer, G. Khaled, J. Fang, H. Maeda, Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov. Today 11, 812–818 (2006)PubMedCrossRef
96.
G. Bergers, L.E. Benjamin, Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer 3, 401–410 (2003)PubMedCrossRef
97.
B. Haley, E. Frenkel, Nanoparticles for drug delivery in cancer treatment. Urol. Oncol. 26, 57–64 (2008)PubMedCrossRef
98.
Y. Matsumura, H. Maeda, A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46, 6387–6392 (1986)PubMed
99.
M.J. Alonso, Nanomedicines for overcoming biological barriers. Biomed. Pharmacother. 58, 168–172 (2004)PubMedCrossRef
100.
101.
P. Decuzzi, S. Lee, B. Bhushan, M. Ferrari, A theoretical model for the margination of particles within blood vessels. Ann. Biomed. Eng. 33, 179–190 (2005)PubMedCrossRef
102.
P. Decuzzi, R. Pasqualini, W. Arap, M. Ferrari, Intravascular delivery of particulate systems: does geometry really matter? Pharm. Res. 26, 235–243 (2009)PubMedCrossRef
103.
V.P. Torchilin, Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4, 145–160 (2005)PubMedCrossRef
104.
H.M. Warenius, G. Galfre, N.M. Bleehen, C. Milstein, Attempted targeting of a monoclonal antibody in a human tumour xenograft system. Eur. J. Cancer Clin. Oncol. 17, 1009–1015 (1981)PubMedCrossRef
105.
D.E.L. De Menezes, L.M. Pilarski, T.M. Allen, In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma. Cancer Res. 58, 3320–3331 (2000)
106.
J.W. Park, K. Hong, D.B. Kirpotin, G. Colbern, R. Shalaby, J. Baselga, Y. Shao, U.B. Nielsen, J.D. Marks, D. Moore, D. Papahadjopoulos, C.C. Benz, Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Clin. Cancer Res. 8, 1172–1181 (2002)PubMed
107.
J. Majoros, B.G. Orr, J.R. Baker, S. Hong, P.R. Leroueil, M.M.B. Holl, The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem. Biol. 14, 107–115 (2007)PubMedCrossRef
108.
D. Peer, P. Zhu, C.V. Carmen, J. Lieberman, M. Shimaoka, Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1. Proc. Natl. Acad. Sci. U. S. A. 104, 4095–4100 (2007)PubMedPubMedCentralCrossRef
109.
O.C. Farokhzad, J. Cheng, B.A. Teply, I. Sherifi, S. Jon, P. Kantoff, J.P. Richie, R. Langer, Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl. Acad. Sci. U. S. A. 103, 6315–6320 (2006)PubMedPubMedCentralCrossRef
110.
Y.N. Dou, J. Zheng, W.D. Foltz, R. Weersink, N. Chaudary, D.A. Jaffray, C. Allen, Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay of cervical carcinoma in mice. J. Control. Release 178, 69–78 (2014)PubMedCrossRef
111.
S. Heilmann, S. Küchler, C. Wischke, A. Lendlein, C. Stein, M. Schäfer-Korting, A thermosensitive morphine-containing hydrogel for the treatment of large-scale skin wounds. Int. J. Pharm. 444, 96–102 (2013)PubMedCrossRef
112.
113.
C. Ju, R. Mo, J. Xue, L. Zhang, Z. Zhao, L. Xue, Q. Ping, C. Zhang, Sequential intra-intercellular nanoparticle delivery system for deep tumor penetration. Angew. Chem. Int. Ed. 53, 6253–6258 (2014)CrossRef
114.
C.L. Lay, J.N. Kumar, C.K. Liu, X. Lu, Y. Liu, A rocket-like encapsulation and delivery system with two-stage booster layers: pH-responsive poly(methacrylic acid)/poly(ethylene glycol) complex-coated hollow silica vesicles. Macromol. Rapid Commun. 34, 1563–1568 (2013)PubMedCrossRef
115.
X. Yao, L. Chen, X. Chen, C. He, J. Zhang, X. Chen, Metallo-supramolecular nanogels for intracellular pH-responsive drug release. Macromol. Rapid Commun. 35, 1697–1705 (2014)PubMedCrossRef
116.
T. Hoare, R. Pelton, Charge-switching, amphoteric glucose-responsive microgels with physiological swelling activity. Biomacromolecules 9, 733–740 (2008)CrossRefPubMed
117.
A. Matsumoto, K. Yamamoto, R. Yoshida, K. Kataoka, T. Aoyagi, Y. Miyahara, A totally synthetic glucose responsive gel operating in physiological aqueous conditions. Chem. Commun. 46, 2203–2205 (2010)CrossRef
118.
S. Mura, J. Nicolas, P. Couvreur, Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 12, 991–1003 (2013)PubMedCrossRef
119.
S. Merino, C. Martin, K. Kostarelos, M. Prato, E. Vazquez, Nanocomposite hydrogels: 3D polymer-nanoparticle synergies for on-demand drug delivery. ACS Nano 9, 4686–4697 (2015)PubMedCrossRef
120.
S. Laurent, D. Forge, M. Port, A. Roch, C. Robic, L. Vander Elst, R.N. Muller, Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 108, 2064–2110 (2008)PubMedCrossRef
121.
M. Sepantafar, R. Maheronnaghsh, H. Mohammadi, F. Radmanesh, M.M. Hasani-Sadrabadi, M. Ebrahimi, Engineered hydrogels in cancer therapy and diagnosis. Trends Biotechnol. 35, 1074–1087 (2017)PubMedCrossRef
122.
T. Tagami, W.D. Foltz, M.J. Ernsting, C.M. Lee, I.F. Tannock, J.P. May, S. Li, MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome. Biomaterials 32, 6570–6578 (2011)PubMedCrossRef
123.
S. Lee, H. Park, J. Choi, Y.N. Park, C. Yun, H. Yoo, Multifunctional nanoparticles for targeted chemophotothermal treatment of cancer cells. Angew. Chem. Int. Ed. 50, 7581–7586 (2011)CrossRef
124.
P. Wust, B. Hildebrandt, G. Sreenivasa, B. Rau, J. Gellermann, H. Riess, R. Felix, P.M. Schlag, Review. Hyperthermia in combined treatment of cancer. Lancet Oncol. 3, 487–497 (2002)PubMedCrossRef
125.
I. Hilger, W.A. Kaiser, Iron oxide-based nanostructures for MRI and magnetic hyperthermia. Nanomedicine 7, 1443–1459 (2012)PubMedCrossRef
126.
P. Pradhan, J. Giri, F. Rieken, C. Koch, O. Mykhaylyk, M. Döblinger, R. Banerjee, D. Bahadur, C. Plank, Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. J. Control. Release 142, 108–121 (2010)PubMedCrossRef
127.
B. Thiesen, A. Jordan, Clinical applications of magnetic nanoparticles for hyperthermia. Int. J. Hyperthermia 24, 467–474 (2008)PubMedCrossRef
128.
J. Gautier, E. Allard-Vannier, E. Munnier, M. Soucé, I. Chourpa, Recent advances in theranostic nanocarriers of doxorubicin based on iron oxide and gold nanoparticles. J. Control. Release 169, 48–61 (2013)PubMedCrossRef
129.
C.S. Brazel, Magnetothermally-responsive nanomaterials: combining magnetic nanostructures and thermally-sensitive polymers for triggered drug release. Pharm. Res. 26, 644–656 (2009)PubMedCrossRef
130.
S. Hu, S. Chen, X. Gao, Multifunctional nanocapsules for simultaneous encapsulation of hydrophilic and hydrophobic compounds and on-demand release. ACS Nano 6, 2558–2565 (2012)PubMedPubMedCentralCrossRef
131.
M. Mahmoudi, S. Sant, B. Wang, S. Laurent, T. Sen, Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv. Drug Deliv. Rev. 63, 24–46 (2011)PubMedCrossRef
132.
W.-H. Chiang, V.T. Ho, H.-H. Chen, W.-C. Huang, Y.-F. Huang, S.-C. Lin, C.-S. Chern, H.-C. Chiu, Superparamagnetic hollow hybrid nanogels as a potential guidable vehicle system of stimuli-mediated MR imaging and multiple cancer therapeutics. Langmuir 29, 6434–6443 (2013)PubMedCrossRef
133.
Z. Deng, Z. Zhen, X. Hu, S. Wu, Z. Xu, P.K. Chu, Hollow chitosan-silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy. Biomaterials 32, 4976–4986 (2011)PubMedCrossRef
134.
K. Hyun, J. Kim, S. Mun, H. Shin, M. Sang, S. Park, H. Lee, R. Park, I. Kim, K. Kim, I. Chan, S. Young, D. Sung, Tumoral acidic pH-responsive MPEG-poly(β-amino ester) polymeric micelles for cancer targeting therapy. J. Control. Release 144, 259–266 (2010)CrossRef
135.
G. Hui Gao, M. Jung Park, Y. Li, G. Ho Im, J. Kim, H. Nyun Kim, J. Won Lee, P. Jeon, O. Young Bang, J. Hee Lee, D. Sung Lee, The use of pH-sensitive positively charged polymeric micelles for protein delivery. Biomaterials 33, 9157–9164 (2012)CrossRef
136.
W. Wu, T. Zhou, A. Berliner, P. Banerjee, S. Zhou, Smart core−shell hybrid nanogels with Ag nanoparticle core for cancer cell imaging and gel shell for pH-regulated drug delivery. Chem. Mater. 22, 1966–1976 (2010)CrossRef
137.
M.E.R. O’Brien, N. Wigler, M. Inbar, R. Rosso, E. Grischke, A. Santoro, R. Catane, D.G. Kieback, P. Tomczak, S.P. Ackland, F. Orlandi, L. Mellars, L. Alland, C. Tendler, Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX™/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. Ann. Oncol. 15, 440–449 (2004)PubMedCrossRef
138.
K.S. Lee, H.C. Chung, S.A. Im, Y.H. Park, C.S. Kim, S.-B. Kim, S.Y. Rha, M.Y. Lee, J. Ro, Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer. Breast Cancer Res. Treat. 108, 241–250 (2008)PubMedCrossRef
139.
P.A. Dinndorf, J. Gootenberg, M.H. Cohen, P. Keegan, R. Pazdur, FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL). Oncologist 12, 991–998 (2007)PubMedCrossRef
140.
T. Okusaka, S. Okada, H. Ueno, M. Ikeda, R. Iwata, H. Furukawa, K. Takayasu, N. Moriyama, T. Sato, K. Sato, Transcatheter arterial embolization with zinostatin stimalamer for hepatocellular carcinoma. Oncology 62, 228–233 (2002)PubMedCrossRef
141.
Q. Song, S.D. Merajver, J.Z. Li, Cancer classification in the genomic era: five contemporary problems. Hum. Genomics 9, 1–8 (2015)CrossRef
142.
L.K. Fung, W.M. Saltzman, Polymeric implants for cancer chemotherapy. Adv. Drug Deliv. Rev. 26, 209–230 (1997)PubMedCrossRef
143.
P.N. Schlegel, Efficacy and safety of histrelin subdermal implant in patients with advanced prostate cancer. J. Urol. 175, 1353–1358 (2006)PubMedCrossRef
144.
D.J. Overstreet, D. Dutta, S.E. Stabenfeldt, B.L. Vernon, Injectable hydrogels. J. Polym. Sci. B Polym. Phys. 50, 881–903 (2012)CrossRef
145.
Y. Li, J. Rodrigues, H. Tomás, Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applications. Chem. Soc. Rev. 41, 2193–2221 (2012)PubMedCrossRef
146.
P. Huang, Y. Zhang, W. Wang, J. Zhou, Y. Sun, J. Liu, D. Kong, J. Liu, A. Dong, Co-delivery of doxorubicin and 131 I by thermosensitive micellar-hydrogel for enhanced in situ synergetic chemoradiotherapy. J. Control. Release 220, 456–464 (2015)PubMedCrossRef
147.
148.
H. Hu, Z. Lin, B. He, W. Dai, X. Wang, J. Wang, X. Zhang, H. Zhang, Q. Zhang, A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel. J. Control. Release 220, 189–200 (2015)PubMedCrossRef
149.
D. Weissglas-Volkov, N. Oliva, E. Friedman, N. Artzi, A. Gilam, N. Shomron, Local microRNA delivery targets Palladin and prevents metastatic breast cancer. Nat. Commun. 7, 12868 (2016)PubMedPubMedCentralCrossRef
150.
S.B. Campbell, T. Hoare, Externally addressable hydrogel nanocomposites for biomedical applications. Curr. Opin. Chem. Eng. 4, 1–10 (2014)CrossRef
151.
S.B. Campbell, M. Patenaude, T. Hoare, Injectable superparamagnets: highly elastic and degradable poly(N-isopropylacrylamide)-superparamagnetic iron oxide nanoparticle (SPION) composite hydrogels. Biomacromolecules 14, 644–653 (2013)PubMedCrossRef
152.
L.E. Strong, S.N. Dahotre, J.L. West, Hydrogel-nanoparticle composites for optically modulated cancer therapeutic delivery. J. Control. Release 178, 63–68 (2014)PubMedPubMedCentralCrossRef
153.
154.
R. Tong, H.D. Hemmati, R. Langer, D.S. Kohane, Photoswitchable nanoparticles for triggered tissue penetration and drug delivery. J. Am. Chem. Soc. 134, 8848–8855 (2012)PubMedPubMedCentralCrossRef
155.
S. Campbell, D. Maitland, T. Hoare, Enhanced pulsatile drug release from injectable magnetic hydrogels with embedded thermosensitive microgels. ACS Macro Lett. 4, 312–316 (2015)CrossRef
156.
P.W. Kantoff, C.S. Higano, N.D. Shore, E.R. Berger, E.J. Small, D.F. Penson, C.H. Redfern, A.C. Ferrari, R. Dreicer, R.B. Sims, Y. Xu, D. Ph, M.W. Frohlich, P.F. Schellhammer, Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N. Engl. J. Med. 363, 411–422 (2012)CrossRef
157.
O. Hamid, C. Robert, A. Daud, F.S. Hodi, W.-J. Hwu, R. Kefford, J.D. Wolchok, P. Hersey, R.W. Joseph, J.S. Weber, R. Dronca, T.C. Gangadhar, A. Patnaik, H. Zarour, A.M. Joshua, K. Gergich, J. Elassaiss-Schaap, A. Algazi, C. Mateus, P. Boasberg, P.C. Tumeh, B. Chmielowski, S.W. Ebbinghaus, X.N. Li, S.P. Kang, A. Ribas, Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N. Engl. J. Med. 369, 134–144 (2013)PubMedPubMedCentralCrossRef
158.
M.A. Postow, J. Chesney, A.C. Pavlick, C. Robert, K. Grossmann, D. McDermott, G.P. Linette, N. Meyer, J.K. Giguere, D. Minor, A.K. Salama, M. Taylor, P.A. Ott, L.M. Rollin, C. Horak, P. Gagnier, J.D. Wolchok, F.S. Hodi, Nivolumab and Ipilimumab versus Ipilimumab in untreated melanoma. N. Engl. J. Med. 372, 2006–2017 (2015)PubMedPubMedCentralCrossRef
159.
O.A. Ali, N. Huebsch, L. Cao, G. Dranoff, D.J. Mooney, Infection-mimicking materials to program dendritic cells in situ. Nat. Mater. 8, 151–158 (2009)PubMedPubMedCentralCrossRef
160.
161.
O.A. Ali, D. Emerich, G. Dranoff, D.J. Mooney, In situ regulation of DC subsets and T cells mediates tumor regression in mice. Sci. Transl. Med. 1, 1–10 (2009)CrossRef
162.
P. Duewell, U. Kisser, K. Heckelsmiller, S. Hoves, P. Stoitzner, S. Koernig, A.B.. Morelli, B.E. Clausen, M. Dauer, A. Eigler, D. Anz, C. Bourquin, E. Maraskovsky, S. Endres, M. Schnurr, ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells. J. Immunol. 187, 55–63 (2015)CrossRef
163.
S.A. Bencherif, R.W. Sands, O.A. Ali, W.A. Li, S.A. Lewin, T.M. Braschler, T. Shih, C.S. Verbeke, D. Bhatta, G. Dranoff, D.J. Mooney, Injectable cryogel-based whole-cell cancer vaccines. Nat. Commun. 6, 1–13 (2015)CrossRef
164.
A.Z. Wang, R. Langer, O.C. Farokhzad, Nanoparticle delivery of cancer drugs. Annu. Rev. Med. 63, 185–198 (2012)PubMedCrossRef
165.
M.E. Davis, J.E. Zuckerman, C.H.J. Choi, D. Seligson, A. Tolcher, C.A. Alabi, Y. Yen, J.D. Heidel, A. Ribas, Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464, 1067–1070 (2010)PubMedPubMedCentralCrossRef
166.
R. Farra, N.F. Sheppard Jr., L. McCabe, R.M. Neer, J.M. Anderson, J.T. Santini Jr., M.J. Cima, R. Langer, First-in-human testing of a wirelessly controlled drug delivery microchip. Sci. Transl. Med. 4, 122ra121 (2012)CrossRef
167.
J. Li, D.J. Mooney, Designing hydrogels for controlled drug delivery. Nat. Rev. Mater. 1, 1–18 (2016)
168.
E. Blanco, H. Shen, M. Ferrari, Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 33, 941–951 (2015)PubMedPubMedCentralCrossRef
169.
G. Oberdorster, Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J. Intern. Med. 267, 89–105 (2009)CrossRef
170.
C.M. Keck, R.H. Müller, Nanotoxicological classification system (NCS) – a guide for the risk-benefit assessment of nanoparticulate drug delivery systems. Eur. J. Pharm. Biopharm. 84, 445–448 (2013)PubMedCrossRef
171.
D. Huh, D.C. Leslie, D. Benjamin, J.P. Fraser, S. Jurek, A. Geraldine, K.S. Thorneloe, M. Allen, D.E. Ingber, A. Human Disease, Model of drug toxicity – induced pulmonary edema in a lung-on-a-chip microdevice. Sci. Transl. Med. 4, 1–8 (2012)CrossRef
172.
J.A. Doudna, E. Charpentier, The new frontier of genome engineering with CRISPR-Cas9. Science 346, 1258096-1–1258096-9 (2014)CrossRef
173.
A.J. Vegas, O. Veiseh, M. Gürtler, J.R. Millman, F.W. Pagliuca, A.R. Bader, J.C. Doloff, J. Li, M. Chen, K. Olejnik, H.H. Tam, S. Jhunjhunwala, E. Langan, S. Aresta-DaSilva, S. Gandham, J.J. McGarrigle, M.A. Bochenek, J. Hollister-Lock, J. Oberholzer, D.L. Greiner, G.C. Weir, D.A. Melton, R. Langer, D.G. Anderson, Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. Nat. Med. 22, 306–311 (2016)PubMedPubMedCentralCrossRef
174.
O. Veiseh, J.C. Dolo, M. Ma, A.J. Vegas, H.H. Tam, A.R. Bader, J. Li, E. Langan, J. Wycko, W.S. Loo, S. Jhunjhunwala, A. Chiu, S. Siebert, K. Tang, J. Hollister-Lock, S. Aresta-Dasilva, M. Bochenek, J. Mendoza-Elias, Y. Wang, M. Qi, D.M. Lavin, M. Chen, N. Dholakia, R. Thakrar, I. Lacík, G.C. Weir, J. Oberholzer, D.L. Greiner, R. Langer, Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates. Nat. Mater. 14, 643–652 (2015)PubMedPubMedCentralCrossRef
175.
A.J. Vegas, O. Veiseh, J.C. Doloff, M. Ma, H.H. Tam, K. Bratlie, J. Li, A.R. Bader, E. Langan, K. Olejnik, P. Fenton, J.W. Kang, J. Hollister-Locke, M.A. Bochenek, A. Chiu, S. Siebert, K. Tang, S. Jhunjhunwala, S. Aresta-DaSilva, N. Dholakia, R. Thakrar, T. Vietti, M. Chen, J. Cohen, K. Siniakowicz, M. Qi, J. McGarrigle, A.C. Graham, S. Lyle, D.M. Harlan, D.L. Greiner, J. Oberholzer, G.C. Weir, R. Langer, Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates. Nat. Biotechnol. 34, 345–352 (2016)PubMedPubMedCentralCrossRef
176.
Y. Zhu, T. Tchkonia, T. Pirtskhalava, A.C. Gower, H. Ding, N. Giorgadze, A.K. Palmer, Y. Ikeno, G.B. Hubbard, S.P.O. Hara, N.F. Larusso, D. Jordan, C.M. Roos, G.C. Verzosa, K. Nathan, J.D. Wren, J.N. Farr, M.B. Stout, S.J. McGowan, A.U. Gurkar, J. Zhao, A. Dorronsoro, Y.Y. Ling, S. Amira, D.C. Navarro, T. Sano, D. Paul, L.J. Niedernhofer, J.L. Kirkland, The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell 14, 644–658 (2015)PubMedPubMedCentralCrossRef
177.
D.J. Baker, T. Wijshake, T. Tchkonia, N.K. Lebrasseur, B.G. Childs, B. Van De Sluis, J.L. Kirkland, J.M. Van Deursen, Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479, 232–236 (2011)PubMedPubMedCentralCrossRef
178.
D. Patra, S. Sengupta, W. Duan, H. Zhang, R. Pavlick, A. Sen, Intelligent, self-powered, drug delivery systems. Nanoscale 5, 1273–1283 (2013)PubMedCrossRef
Metadata
Title
Drug Delivery: Localized and Systemic Therapeutic Strategies with Polymer Systems
Authors
Scott Campbell
Niels Smeets
Copyright Year
2019
Book
Functional Polymers

Print ISBN: 978-3-319-95986-3

Electronic ISBN: 978-3-319-95987-0

Copyright Year: 2019

DOI
https://doi.org/10.1007/978-3-319-95987-0_32

Premium Partners

    Image Credits